BBH

VanEck Vectors Biotech ETF

Up$136.10
+$0.58
(+0.43%)
As of 4:58:24 PM EDT | 11/20/19  |  Market Closed

BBH Trading Data

Open

$135.25

Low Price

$135.1

High Price

$136.41

Previous Last Price

$135.52

Bid Size

$133.59 X 700

Ask Size

$138.73 X 700

BBH Portfolio Data

AUM

$358,256,700

Shares

2,647

PE Ratio

19.24

Price / Book Ratio

3.94

Expense Ratio

0.35

Net Asset Value

$135.37

Volume

Volume

13,507

Avg. Volume (YDT)

15,789

Dollar Volume

$1,426,842

Weekly Avg. Volume

17,740

Monthly Avg. Volume

14,820

Quarterly Avg. Volume

15,351

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Holdings

Top 10 Holdings

Amgen Inc (AMGN)
10.81%
Celgene Corp (CELG)
7.03%
Gilead Sciences Inc (GILD)
6.64%
Vertex Pharmaceuticals Inc (VRTX)
5.54%
Biogen Inc (BIIB)
5.47%
Allergan Plc (AGN)
5.11%
Regeneron Pharmaceuticals Inc (REGN)
5.01%
Illumina Inc (ILMN)
4.83%
Incyte Corp (INCY)
4.55%
Iqvia Holdings Inc (IQV)
4.46%

Total BBH Holdings

Total Holdings: 27

Amgen Inc (AMGN)
10.81%
Celgene Corp (CELG)
7.03%
Gilead Sciences Inc (GILD)
6.64%
Vertex Pharmaceuticals Inc (VRTX)
5.54%
Biogen Inc (BIIB)
5.47%
Allergan Plc (AGN)
5.11%
Regeneron Pharmaceuticals Inc (REGN)
5.01%
Illumina Inc (ILMN)
4.83%
Incyte Corp (INCY)
4.55%
Iqvia Holdings Inc (IQV)
4.46%
Alexion Pharmaceuticals Inc (ALXN)
4.1%
Beigene Ltd (BGNE)
3.88%
Qiagen Nv (QGEN)
3.76%
Biomarin Pharmaceutical Inc (BMRN)
3.73%
Neurocrine Biosciences Inc (NBIX)
3.25%
Exact Sciences Corp (EXAS)
3.11%
Charles River Laboratories Internationa (CRL)
2.89%
Alnylam Pharmaceuticals Inc (ALNY)
2.83%
Sarepta Therapeutics Inc (SRPT)
2.74%
Grifols Sa (GRFS)
2.53%
Seattle Genetics Inc (SGEN)
2.49%
Guardant Health Inc (GH)
1.94%
Ionis Pharmaceuticals Inc (IONS)
1.71%
United Therapeutics Corp (UTHR)
1.22%
Bluebird Bio Inc (BLUE)
0.44%
Market Vectors Biotech ETF (BBH)
0%
Other/Cash
0%

BBH Technicals

Alpha

-9.18

Beta

1.29

Leverage

Long

Standard Deviation

4.92

BBH Dividends

Dividend Date

2018-12-20

Latest Dividend

5.551

Annual Dividend

5.55

Annual Dividend Rate

5.55

Annual Dividend Yield

4.1

BBH Performance

YTD Return

22.93%

1 Year Return

16.81%

3 Year Return

21.11%

5 Year Return

15.74%

10 Year Return

317.88%

BBH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.